UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Infectious diseases and therapy, 2022-04, Vol.11 (2), p.661-682

2022

Volltextzugriff (PDF)

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model

Microbiology spectrum, 2023-08, Vol.11 (4), p.e0034023

2023

Volltextzugriff (PDF)

Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens

Microbiology spectrum, 2024-07, Vol.12 (10), p.e0042724

2024

Volltextzugriff (PDF)

Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection

Microbiology spectrum, 2021-10, Vol.9 (2), p.e0046421-e0046421

2021

Volltextzugriff (PDF)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0264722-e0264722

2023

Volltextzugriff (PDF)

Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections

Microbiology spectrum, 2024-02, Vol.12 (2), p.e0310823-e0310823

2024

Volltextzugriff (PDF)

Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0138823

2024

Volltextzugriff (PDF)

Impact of obesity on clinical outcomes of methicillin-susceptible Staphylococcus aureus bloodstream infections

Antimicrobial agents and chemotherapy, 2024-09

2024

Volltextzugriff (PDF)

Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections

Pharmacotherapy, 2023-06, Vol.43 (6), p.502-513

2023

Volltextzugriff (PDF)

Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia

Pharmacotherapy, 2023-08, Vol.43 (8), p.833-846

2023

Volltextzugriff (PDF)

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0072823-e0072823

2023

Volltextzugriff (PDF)

Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection

Antimicrobial agents and chemotherapy, 2022-10, Vol.66 (10), p.e0064622-e0064622

2022

Volltextzugriff (PDF)

CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis

Journal of pediatric gastroenterology and nutrition, 2019-11, Vol.69 (5), p.581-587

2019

Volltextzugriff (PDF)

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e1444-e1455

2023

Volltextzugriff (PDF)

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Open forum infectious diseases, 2022-04, Vol.9 (4), p.ofac092

2022

Volltextzugriff (PDF)

Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms

Microbiology spectrum, 2024-04, Vol.12 (4), p.e0321223-e0321223

2024

Volltextzugriff (PDF)

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Open forum infectious diseases, 2023-03, Vol.10 (3), p.ofad034-ofad034

2023

Volltextzugriff (PDF)

Miliary Histoplasmosis in a Renal Transplant Patient

Curēus (Palo Alto, CA), 2021-11

2021

Volltextzugriff (PDF)

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

Open forum infectious diseases, 2023-09, Vol.10 (9), p.ofad454

2023

Volltextzugriff (PDF)

Post‐graduate pharmacy fellowships: The current state of affairs

JAACP : Journal of the American College of Clinical Pharmacy, 2023-02, Vol.6 (2), p.145-153

2023

Volltextzugriff (PDF)

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

Infectious diseases and therapy, 2022-10, Vol.11 (5), p.1965-1980

2022

Volltextzugriff (PDF)

Penicillin allergy reassessment for treatment improvement

The Journal of the American Dental Association (1939), 2024-05, Vol.155 (5), p.379-389

2024

Volltextzugriff (PDF)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

2066. Synergistic Bacteriophage-Antibiotic Combinations Against High Inoculum DNS MRSA

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaBiofilms

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Microbiology
(15)
Humans
(7)
Pharmacology & Pharmacy
(7)
Pseudomonas Aeruginosa
(7)
Research Article
(7)
Antimicrobial Chemotherapy
(6)
Bacteriophage
(6)
Infectious Diseases
(6)
Anti-Bacterial Agents - Adverse Effects
(5)
Microbial Sensitivity Tests
(5)
Pneumonia
(5)
Retrospective Studies
(5)
Immunology
(4)
Acinetobacter Baumannii
(3)
Antibacterial Agents
(3)
Antibiotics
(3)
Antimicrobial Stewardship
(3)
Bacteriophages
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model

Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens

Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections

Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

Impact of obesity on clinical outcomes of methicillin-susceptible Staphylococcus aureus bloodstream infections

Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections

Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection

CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report

Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Miliary Histoplasmosis in a Renal Transplant Patient

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

Post‐graduate pharmacy fellowships: The current state of affairs

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

Penicillin allergy reassessment for treatment improvement

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

2066. Synergistic Bacteriophage-Antibiotic Combinations Against High Inoculum DNS MRSA

Aktive Filter

Suchergebnisse filtern